Evidence map›Paper›PMID 32972761›Full record

ArticleTransplantation proceedings2020

Minimal Change Disease With Nephrotic Syndrome Associated With Coronavirus Disease 2019 After Apolipoprotein L1 Risk Variant Kidney Transplant: A Case Report.

Masaaki Yamada, Prerna Rastogi, Dilek Ince, Abdullah Thayyil, M Adela Mansilla, Richard J H Smith, Sarat Kuppachi, Christie P Thomas

Open access · greenAbstract readCase Reports
In one paragraph

Article in Transplantation proceedings, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Kidney allograft biopsy findings after COVID-19.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. COVID-19 Minisymposium: Toward a Strategic Roadmap.Transplantation proceedings · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Masaaki YamadaDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa; VA Medical Center, Iowa City, Iowa.
Prerna RastogiDepartment of Pathology, University of Iowa, Iowa City, Iowa.
Dilek InceDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa.
Abdullah ThayyilDepartment of Pathology, East Carolina University, Greenville, North Carolina; Department of Pathology, Vidant Medical Center, Greenville, North Carolina.
M Adela MansillaIowa Institute of Human Genetics, University of Iowa, Iowa City, Iowa.
Richard J H SmithDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa; Iowa Institute of Human Genetics, University of Iowa, Iowa City, Iowa.
Sarat KuppachiDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa. Electronic address: sarat-kuppachi@uiowa.edu.
Christie P ThomasDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa; VA Medical Center, Iowa City, Iowa.
University of Iowa · USVidant Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney injury is a well-known complication in people with coronavirus disease 2019 (COVID-19). In kidney transplant recipients with COVID-19, presentation with nephrotic syndrome has not been well described. We report on a 49-year-old black female kidney transplant recipient who presented 25 years after transplant with clinical features of nephrotic syndrome following a diagnosis of COVID-19. Histologic examination showed acute tubular injury with unremarkable glomeruli on light microscopy and diffuse foot process effacement of podocytes on electron microscopy, consistent with minimal change-like podocyte injury. Apolipoprotein L1 (APOL1) genetic testing confirmed 2 high-risk APOL1 alleles in the kidney donor. We speculate that COVID-19-induced systemic or local cytokine release could serve as a second hit in the presence of APOL1 risk alleles and mediate a podocytopathy manifesting as nephrotic syndrome. The presented case with minimal change-like disease, occurring in the context of the donor high-risk APOL1 genotype, extends the spectrum of clinical manifestations in COVID-19-associated nephropathy.

Indexed as

Immunocompromised HostApolipoprotein L1BetacoronavirusCoronavirus InfectionsCOVID-19FemaleHumansKidney TransplantationMiddle AgedNephrosis, LipoidPandemicsPneumonia, ViralSARS-CoV-2APOL1 protein, humanApolipoprotein L1

Identifiers

PMID32972761
PMCPMC7440148
OpenAlexW3073071153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.